1. microRNAs‐based diagnostic and therapeutic applications in liver fibrosis
   Xingtao Zhao et al, 2023, WIREs RNA CrossRef
2. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
   Xiaoqiang Gao et al, 2023, Clinical and Experimental Medicine CrossRef
3. Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C
   Anna Kleczka et al, 2023, Diagnostics CrossRef
4. Characterization of aggrephagy-related genes to predict the progression of liver fibrosis from multi-omics profiles
   Jing Chen et al, 2024, Biomedical Technology CrossRef
5. The immune and metabolic treatment approach of using testosterone on mice models of liver injury
   Johnny Amer et al, 2023, Frontiers in Pharmacology CrossRef
6. Roles and therapeutic targeting of dendritic cells in liver fibrosis
   Bingyu Wang et al, 2024, Journal of Drug Targeting CrossRef
7. Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
   Shuang Wang et al, 2023, Science Translational Medicine CrossRef
8. Jaceosidin attenuates the progression of hepatic fibrosis by inhibiting the VGLL3/HMGB1/TLR4 signaling pathway
   Youli Yao et al, 2024, Phytomedicine CrossRef
9. Insights into the impact of hepatitis B virus on hepatic stellate cell activation
   Hongjuan You et al, 2023, Cell Communication and Signaling CrossRef
10. Interleukin‐33 and liver natural killer cells: A novel perspective on antitumor activity in liver fibrosis
    Yuki Imaoka et al, 2024, Hepatology Research CrossRef
11. Interleukin-10 gene intervention ameliorates liver fibrosis by enhancing the immune function of natural killer cells in liver tissue
    Yizhen Chen et al, 2024, International Immunopharmacology CrossRef
12. Progressive dysfunction of the immune system as a factor preventing recoverable regeneration of the liver in chronic fibrosing diseases
    Н.А. Онищенко et al, 2023, Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» CrossRef
13. Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis
    Xiaochen Liu et al, 2024, Human Immunology CrossRef
14. Innate immunity and early liver inflammation
    Jordi Yang Zhou, 2023, Frontiers in Immunology CrossRef
15. Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells
    Julia Sauer et al, 2024, Frontiers in Immunology CrossRef
16. Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
    Melissa Myint et al, 2023, Journal of Translational Medicine CrossRef
17. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
    Jinyu Zhao et al, 2024, Medical Review CrossRef
18. Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis
    Diren Beyoğlu et al, 2023, Cells CrossRef
19. Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
    Ana C. Maretti-Mira et al, 2023, Frontiers in Immunology CrossRef
20. Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
    Nana Zhang et al, 2023, Frontiers in Immunology CrossRef
21. Subpopulation composition of blood NK cells in patients with hepatitis C with genotype 1 or 3
    V. V. Tsukanov et al, 2023, Meditsinskiy sovet = Medical Council CrossRef